- ISIN
- US00091E1091
- CUSIP
- 00091E109
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Jul 22, 2021
Highlights
- Market Cap
- $971.31M
- Enterprise Value
- $968.95M
- EPS (TTM)
- -$0.82
- Total Revenue (TTM)
- $1.62M
- Gross Profit (TTM)
- -$21.67M
- EBITDA (TTM)
- -$115.23M
- Year Range
- $2.24 - $7.34
- Target Price
- $6.16
- ROA (TTM)
- -60.55%
- ROE (TTM)
- -68.87%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ABSI Performance Chart
Absci Corporation (ABSI) is up 82.0% since the beginning of the year. At $6 per share, ABSI is trading 13.5% below its 52-week high of $7.
Loading charts...
Returns By Period
Absci Corporation (ABSI) has returned 81.95% so far this year and 132.60% over the past 12 months.
Absci Corporation
- 1D
- -2.61%
- 1M
- 29.07%
- YTD
- 81.95%
- 6M
- 109.57%
- 1Y
- 132.60%
- 3Y*
- 50.04%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 0.13%
- 1M
- 5.25%
- YTD
- 11.16%
- 6M
- 11.43%
- 1Y
- 28.20%
- 3Y*
- 21.12%
- 5Y*
- 12.66%
- 10Y*
- 13.75%
ABSI Monthly Returns History
Based on dividend-adjusted daily data since Jul 22, 2021, ABSI's average daily return is +0.08%, while the average monthly return is +2.10%. At this rate, an investment would double in approximately 2.8 years.
Historically, 40% of months were positive and 60% were negative. The best month was Dec 2023 with a return of +151.5%, while the worst month was May 2022 at -38.2%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 5 months.
On a daily basis, ABSI closed higher 49% of trading days. The best single day was May 22, 2023 with a return of +30.2%, while the worst single day was Nov 13, 2025 at -22.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -14.33% | -8.36% | 9.49% | 65.83% | 35.68% | -5.93% | 81.95% | ||||||
| 2025 | 41.60% | 3.77% | -34.81% | 22.31% | -13.68% | -3.02% | 10.12% | -15.55% | 27.20% | 40.79% | -25.93% | 10.09% | 33.21% |
| 2024 | -5.71% | 30.30% | 10.08% | -16.55% | -11.18% | -26.84% | 42.86% | -0.00% | -13.18% | 0.52% | -20.57% | -14.10% | -37.62% |
| 2023 | 49.52% | -32.48% | -17.45% | -24.57% | 43.94% | -20.00% | 44.74% | -18.64% | -26.26% | -1.52% | 28.46% | 151.50% | 100.00% |
| 2022 | -17.93% | 39.23% | -10.03% | -29.89% | -38.24% | -9.04% | -0.90% | 2.43% | -7.12% | 0.96% | -20.89% | -16.00% | -74.39% |
| 2021 | 31.91% | -34.06% | -38.07% | 26.14% | -28.08% | -22.27% | -62.02% |
Benchmark Metrics
Absci Corporation has an annualized alpha of -7.41%, beta of 2.20, and R2 of 0.15 versus S&P 500 Index. Calculated based on daily prices since July 23, 2021.
- This stock participated in 205.00% of S&P 500 Index downside but only 103.97% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.15 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -7.41%
- Beta
- 2.20
- R²
- 0.15
- Upside Capture
- 103.97%
- Downside Capture
- 205.00%
Return for Risk
Risk / Return Rank
ABSI ranks 77 for risk / return — better than 77% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Absci Corporation (ABSI) and compare them to S&P 500 Index.
| ABSI | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.43 | 2.39 | -0.95 |
Sortino ratioReturn per unit of downside risk | 2.28 | 3.25 | -0.97 |
Omega ratioGain probability vs. loss probability | 1.27 | 1.43 | -0.16 |
Calmar ratioReturn relative to maximum drawdown | 2.47 | 3.11 | -0.64 |
Martin ratioReturn relative to average drawdown | 4.54 | 14.38 | -9.84 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Absci Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Absci Corporation was 96.20%, occurring on Oct 26, 2023. The portfolio has not yet recovered.
The current Absci Corporation drawdown is 79.04%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2023 bear market2023 | -96.20%Oct 2023 | 2y 2mo | — | 4y 10moAug 2021 - now |
2021 pullback2021 | -1.23%Jul 2021 | 0s | 1d | 1dJul 2021 - Jul 2021 |
2021 pullback2021 | -0.21%Jul 2021 | 0s | 3d | 3dJul 2021 - Aug 2021 |
Drawdown Indicators
| ABSI | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.20% | -56.78% | -39.42% |
Max Drawdown (1Y)Largest decline over 1 year | -54.00% | -9.10% | -44.90% |
Max Drawdown (3Y)Largest decline over 3 years | -66.06% | -18.90% | -47.16% |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -79.04% | 0.00% | -79.04% |
Average DrawdownAverage peak-to-trough decline | -84.81% | -10.72% | -74.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 29.31% | 1.97% | +27.34% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Absci Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Absci Corporation is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ABSI relative to other companies in the Biotechnology industry. Currently, ABSI has a P/S ratio of 563.1. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ABSI in comparison with other companies in the Biotechnology industry. Currently, ABSI has a P/B value of 5.6. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ABSI
Add Absci Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ABSI